These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 15982354)

  • 1. Co-operative signalling mechanisms required for erythroid precursor expansion in response to erythropoietin and stem cell factor.
    Arcasoy MO; Jiang X
    Br J Haematol; 2005 Jul; 130(1):121-9. PubMed ID: 15982354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell factor and erythropoietin inhibit apoptosis of human erythroid progenitor cells through different signalling pathways.
    Sui X; Krantz SB; Zhao ZJ
    Br J Haematol; 2000 Jul; 110(1):63-70. PubMed ID: 10930980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis.
    Sui X; Krantz SB; You M; Zhao Z
    Blood; 1998 Aug; 92(4):1142-9. PubMed ID: 9694701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
    Tong W; Zhang J; Lodish HF
    Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of phosphatidylinositol 3-kinase is important for erythropoietin-induced erythropoiesis from CD34(+) hematopoietic progenitor cells.
    Myklebust JH; Blomhoff HK; Rusten LS; Stokke T; Smeland EB
    Exp Hematol; 2002 Sep; 30(9):990-1000. PubMed ID: 12225790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct functions of erythropoietin and stem cell factor are linked to activation of mTOR kinase signaling pathway in human erythroid progenitors.
    Geslain R; Uddin S; Liu H; Jiang H; van Besien K; Pan T; Wickrema A
    Cytokine; 2013 Jan; 61(1):329-35. PubMed ID: 23148990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation.
    Erickson-Miller CL; Pelus LM; Lord KA
    Stem Cells; 2000; 18(5):366-73. PubMed ID: 11007921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the Akt/FKHRL1 pathway mediates the antiapoptotic effects of erythropoietin in primary human erythroid progenitors.
    Uddin S; Kottegoda S; Stigger D; Platanias LC; Wickrema A
    Biochem Biophys Res Commun; 2000 Aug; 275(1):16-9. PubMed ID: 10944433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
    Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
    J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of erythropoiesis by erythropoietin and stem cell factor: a novel role for Bruton's tyrosine kinase.
    von Lindern M; Schmidt U; Beug H
    Cell Cycle; 2004 Jul; 3(7):876-9. PubMed ID: 15254422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin-mediated protection of insect brain neurons involves JAK and STAT but not PI3K transduction pathways.
    Miljus N; Heibeck S; Jarrar M; Micke M; Ostrowski D; Ehrenreich H; Heinrich R
    Neuroscience; 2014 Jan; 258():218-27. PubMed ID: 24269933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical measurements on single erythroid progenitor cells shed light on the combinatorial regulation of red blood cell production.
    Wang W; Akbarian V; Audet J
    Mol Biosyst; 2013 Feb; 9(2):234-45. PubMed ID: 23168618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epo regulates erythroid proliferation and differentiation through distinct signaling pathways: implication for erythropoiesis and Friend virus-induced erythroleukemia.
    Zochodne B; Truong AH; Stetler K; Higgins RR; Howard J; Dumont D; Berger SA; Ben-David Y
    Oncogene; 2000 May; 19(19):2296-304. PubMed ID: 10822380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-stimulation with stem cell factor and erythropoietin enhances migration of c-Kit expressing cervical cancer cells through the sustained activation of ERK1/2.
    Aguilar C; Aguilar C; Lopez-Marure R; Jiménez-Sánchez A; Rocha-Zavaleta L
    Mol Med Rep; 2014 May; 9(5):1895-902. PubMed ID: 24626629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lyn kinase plays important roles in erythroid expansion, maturation and erythropoietin receptor signalling by regulating inhibitory signalling pathways that control survival.
    Slavova-Azmanova NS; Kucera N; Louw A; Satiaputra J; Handoko A; Singer P; Stone L; McCarthy DJ; Klinken SP; Hibbs ML; Ingley E
    Biochem J; 2014 May; 459(3):455-66. PubMed ID: 24552351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycythemia vera erythroid precursors exhibit increased proliferation and apoptosis resistance associated with abnormal RAS and PI3K pathway activation.
    Laubach JP; Fu P; Jiang X; Salter KH; Potti A; Arcasoy MO
    Exp Hematol; 2009 Dec; 37(12):1411-22. PubMed ID: 19815050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PI3 kinase is important for Ras, MEK and Erk activation of Epo-stimulated human erythroid progenitors.
    Schmidt EK; Fichelson S; Feller SM
    BMC Biol; 2004 May; 2():7. PubMed ID: 15149544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation.
    Bouscary D; Pene F; Claessens YE; Muller O; Chrétien S; Fontenay-Roupie M; Gisselbrecht S; Mayeux P; Lacombe C
    Blood; 2003 May; 101(9):3436-43. PubMed ID: 12506011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined inhibition of PI3K and activation of MAPK p38 signaling pathways trigger erythroid alternative splicing switch of 4.1R pre-mRNA in DMSO-induced erythroleukemia cells.
    Breig O; Théoleyre-Schaal O; Baklouti F
    Cell Signal; 2013 Dec; 25(12):2453-61. PubMed ID: 23993958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.